Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 596

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Oral Azole Drugs as Systemic Antifungal Therapy

Wood, Alastair J.J., Como, Jackson A., Dismukes, William E.·1994·New England Journal of Medicine

Abstract

The oral azole drugs--ketoconazole, fluconazole, and itraconazole--represent a major advance in systemic antifungal therapy. Among the three, fluconazole has the most attractive pharmacologic profile, including the capacity to produce high concentrations of active drug in cerebrospinal fluid and urine. Ketoconazole, the first oral azole to be introduced, is less well tolerated than either fluconazole or itraconazole and is associated with more clinically important toxic effects, including hepatitis and inhibition of steroid hormone synthesis. However, ketoconazole is less expensive than fluconazole and itraconazole--an especially important consideration for patients receiving long-term therapy. All three drugs are effective alternatives to amphotericin B and flucytosine as therapy for selected systemic mycoses. Ketoconazole and itraconazole are effective in patients with the chronic, indolent forms of the endemic mycoses, including blastomycosis, coccidioidomycosis, and histoplasmosis; itraconazole is also effective in patients with sporotrichosis. Fluconazole is useful in the common forms of fungal meningitis--namely, coccidioidal and cryptococcal meningitis. In addition, fluconazole is effective for selected patients with serious candida syndromes such as candidemia, and itraconazole is the most effective of the azoles for the treatment of aspergillosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejm199401273300407

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 112

  1. 10.1093/clinids/12.2.308 · DOI · Paper page
  2. Joly V, 1992, Antimicrob Agents Chemother, 36, 1799, 10.1128/AAC.36.9.1799 · DOI
  3. Van den Bossche H, 1983, Biochem Soc Trans, 11, 665, 10.1042/bst0110665 · DOI · Paper page
  4. Sud IJ, 1979, Antimicrob Agents Chemother, 16, 660, 10.1128/AAC.16.5.660 · DOI
  5. 10.1080/00362178085380351 · DOI
  6. 10.1093/clind/15.6.1003 · DOI · Paper page
  7. 10.1210/jcem-57-4-732 · DOI · Paper page
  8. 10.1172/JCI110903 · DOI · Paper page
  9. 10.1001/archinte.144.11.2150 · doi:10.1001/archinte.144.11.2150
  10. 10.1002/ddr.430080133 · DOI
  11. Hanger DP, 1988, Antimicrob Agents Chemother, 32, 646, 10.1128/AAC.32.5.646 · DOI
  12. 10.2165/00003088-198308010-00002 · DOI · Paper page
  13. 10.2165/00003495-198937030-00003 · DOI · Paper page
  14. Saag MS, 1988, Antimicrob Agents Chemother, 32, 1, 10.1128/AAC.32.1.1 · DOI · Paper page
  15. 10.1007/BF00558308 · DOI · Paper page
  16. Hardin TC, 1988, Antimicrob Agents Chemother, 32, 1310, 10.1128/AAC.32.9.1310 · DOI · Paper page
  17. Barone JA, 1993, Antimicrob Agents Chemother, 37, 778, 10.1128/AAC.37.4.778 · DOI · Paper page
  18. Tucker RM, 1988, Antimicrob Agents Chemother, 32, 369, 10.1128/AAC.32.3.369 · DOI · Paper page
  19. Humphrey MJ, 1985, Antimicrob Agents Chemother, 28, 648, 10.1128/AAC.28.5.648 · DOI · Paper page
  20. Brammer KW, 1991, Drug Metab Dispos Biol Fate Chem, 19, 764
  21. Hostetler JS, 1992, Antimicrob Agents Chemother, 36, 477, 10.1128/AAC.36.2.477 · DOI
  22. Blum RA, 1991, Ann Intern Med, 114, 755, 10.7326/0003-4819-114-9-755 · DOI · Paper page
  23. 10.1016/S0190-9622(88)70037-7 · DOI · Paper page
  24. Lazar JD, 1990, Semin Oncol, 17, 14
  25. 10.1093/jac/21.1.93 · DOI
  26. Boelaert J, 1988, Antimicrob Agents Chemother, 32, 1595, 10.1128/AAC.32.10.1595 · DOI
  27. Toon S, 1990, Br J Clin Pharmacol, 29, 221, 10.1111/j.1365-2125.1990.tb03623.x · DOI
  28. 10.2165/00003088-199018060-00006 · doi:10.2165/00003088-199018060-00006
  29. Hector RF, 1990, Antimicrob Agents Chemother, 34, 448, 10.1128/AAC.34.3.448 · DOI
  30. 10.1159/000238951 · DOI
  31. Galgiani JN, 1987, Antimicrob Agents Chemother, 31, 1867, 10.1128/AAC.31.12.1867 · DOI
  32. Galgiani JN, 1993, Antimicrob Agents Chemother, 37, 2517, 10.1128/AAC.37.12.2517 · DOI
  33. Fan-Havard P, 1991, Antimicrob Agents Chemother, 35, 2302, 10.1128/AAC.35.11.2302 · DOI
  34. 10.1093/jac/31.4.463 · DOI · Paper page
  35. 1993, Antimicrob Agents Chemother, 37, 2443, 10.1128/AAC.37.11.2443 · DOI
  36. Cameron ML, 1993, Antimicrob Agents Chemother, 37, 2449, 10.1128/AAC.37.11.2449 · DOI
  37. Terrell CL, 1992, Mayo Clin Proc, 67, 69, 10.1016/S0025-6196(12)60281-X · DOI
  38. 10.1093/jac/26.4.561 · DOI · Paper page
  39. Lewis JH, 1984, Gastroenterology, 86, 503, 10.1016/S0016-5085(84)80021-9 · DOI · Paper page
  40. 10.1001/archinte.151.5.1020 · doi:10.1001/archinte.151.5.1020
  41. 10.1056/NEJM199203193261203 · DOI · Paper page
  42. 1985, Ann Intern Med, 103, 861, 10.7326/0003-4819-103-6-861 · DOI
  43. Sharkey PK, 1991, Antimicrob Agents Chemother, 35, 707, 10.1128/AAC.35.4.707 · DOI
  44. Phillips P, 1987, Antimicrob Agents Chemother, 31, 647, 10.1128/AAC.31.4.647 · DOI
  45. 10.1093/clinids/14.1.165 · DOI · Paper page
  46. Piscitelli SC, 1991, Antimicrob Agents Chemother, 35, 1765, 10.1128/AAC.35.9.1765 · DOI
  47. 10.1093/clinids/12.Supplement_3.S327 · DOI · Paper page
  48. Apseloff G, 1991, J Clin Pharmacol, 31, 358, 10.1002/j.1552-4604.1991.tb03718.x · DOI
  49. 10.1056/NEJM198412273112606 · DOI
  50. Kramer MR, 1990, Ann Intern Med, 113, 327, 10.7326/0003-4819-113-4-327 · DOI
  51. 10.1001/jama.264.21.2788 · doi:10.1001/jama.264.21.2788 · Paper page
  52. 10.1001/jama.269.12.1513 · DOI
  53. 10.1093/clind/16.3.400 · DOI
  54. Lopez-Gil JA, 1993, Ann Pharmacother, 27, 427, 10.1177/106002809302700405 · DOI
  55. 10.1038/clpt.1987.179 · DOI
  56. 10.1038/clpt.1985.42 · DOI
  57. Back DJ, 1991, Br J Clin Pharmacol, 32, 624, 10.1111/j.1365-2125.1991.tb03963.x · DOI · Paper page
  58. 10.1001/archinte.148.12.2642 · DOI · Paper page
  59. 10.1001/archinte.149.10.2226 · doi:10.1001/archinte.149.10.2226 · Paper page
  60. 10.1093/clinids/14.4.875 · DOI · Paper page
  61. 10.1093/clinids/14.Supplement_1.S106 · DOI
  62. 10.1016/0002-9343(89)90475-0 · DOI · Paper page
  63. 10.1016/0190-9622(90)70263-H · DOI · Paper page
  64. Bradsher RW, 1985, Ann Intern Med, 103, 872, 10.7326/0003-4819-103-6-872 · DOI
  65. 10.1016/0002-9343(92)90575-V · DOI · Paper page
  66. Pappas PG, Bradsher RW, Chapman SW, et al. Fluconazole in the treatment of blastomycosis. In: Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, September 29-October 2, 1991. Washington, D.C.: American Society for Microbiology, 1991:292. abstract.
  67. 10.1093/infdis/164.6.1232 · DOI
  68. 10.1093/clinids/14.4.952 · DOI
  69. 10.1093/clinids/14.Supplement_1.S161 · DOI · Paper page
  70. Rex JH, Bennett JE, Sugar AM, et al. Fluconazole vs. amphotericin B for treatment of candidemia: results of a randomized multicenter trial. In: Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, October 17-20, 1993. Washington, D.C.: American Society for Microbiology, 1993:267. abstract.
  71. 10.1016/0002-9343(91)90005-I · DOI · Paper page
  72. 10.1016/0002-9343(91)90006-J · DOI · Paper page
  73. 10.1093/clind/16.5.677 · DOI · Paper page
  74. 10.1016/0002-9343(88)90143-X · DOI
  75. 10.1016/0002-9343(90)90339-F · DOI · Paper page
  76. 10.1378/chest.97.3.666 · DOI
  77. 10.1093/clinids/14.Supplement_1.S68 · DOI
  78. Galgiani JN, 1993, Ann Intern Med, 119, 28, 10.7326/0003-4819-119-1-199307010-00005 · DOI · Paper page
  79. Tucker RM, 1990, Ann Intern Med, 112, 108, 10.7326/0003-4819-112-2-108 · DOI
  80. 10.1056/NEJM199201093260202 · DOI · Paper page
  81. Berry AJ, 1992, Antimicrob Agents Chemother, 36, 690, 10.1128/AAC.36.3.690 · DOI
  82. Denning DW, Tucker RM, Hostetler JS, Gill S, Stevens DA. Oral itraconazole therapy of cryptococcal meningitis and cryptococcosis in patients with AIDS. In: Vanden Bossche H, Mackenzie DWR, Cauwenbergh G, Van Cutsem J, Drouhet E, Dupont B, eds. Mycoses in AIDS patients. New York: Plenum Press, 1990:305-24. · DOI
  83. 10.1097/00002030-199202000-00007 · DOI
  84. 10.1056/NEJM199102283240902 · DOI · Paper page
  85. 10.1093/clinids/2.4.643 · DOI
  86. Wheat LJ, Hafner RE, Wulfsohn M, Johnson J, Owens S. Itraconazole (Itra) is effective treatment for histoplasmosis in AIDS: prospective multicenter noncomparative trial. In: Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, Calif., October 10-14, 1992. Washington, D.C.: American Society for Microbiology, 1992:312. abstract.
  87. Wheat J, 1993, Ann Intern Med, 118, 610, 10.7326/0003-4819-118-8-199304150-00006 · DOI · Paper page
  88. 10.1016/0002-9343(83)90513-2 · DOI
  89. 10.1093/clinids/9.Supplement_1.S51 · DOI
  90. 10.1001/archderm.122.4.413 · doi:10.1001/archderm.122.4.413 · Paper page
  91. 10.1016/0002-9343(93)90280-3 · DOI
  92. Savani DV, 1987, Antimicrob Agents Chemother, 31, 6, 10.1128/AAC.31.1.6 · DOI · Paper page
  93. 10.1056/NEJM197907193010303 · DOI · Paper page
  94. 10.1056/NEJM198708063170602 · DOI · Paper page
  95. 10.1056/NEJM198909213211205 · DOI · Paper page
  96. Larsen RA, 1990, Ann Intern Med, 113, 183, 10.7326/0003-4819-113-3-183 · DOI · Paper page
  97. 10.1093/infdis/165.5.960 · DOI
  98. Milefchik E, Leal M, Hanbrich R, See D, Bozzette S, Larsen R. High dose fluconazole with and without flucytosine for AIDS-associated cryptococcal meningitis. In: Abstracts of the Ninth International Conference on AIDS/ Fourth STD World Congress, Berlin, Germany, June 6-11, 1993. Vol. I. Abstract book.
  99. 10.1097/00002030-199202000-00008 · DOI
  100. Aisner J, 1977, Ann Intern Med, 86, 539, 10.7326/0003-4819-86-5-539 · DOI · Paper page
  101. Burch PA, 1987, J Clin Oncol, 5, 1985, 10.1200/JCO.1987.5.12.1985 · DOI · Paper page
  102. 10.1378/chest.100.3.813 · DOI · Paper page
  103. 10.1016/S0140-6736(82)91874-8 · DOI
  104. 10.1093/infdis/152.6.1257 · DOI
  105. 10.1093/clinids/9.Supplement_1.S94 · DOI · Paper page
  106. 10.1016/0002-9343(87)90949-1 · DOI
  107. 10.1111/j.1439-0507.1989.tb02299.x · DOI · Paper page
  108. 10.1093/jac/27.3.369 · DOI
  109. Winston DJ, 1993, Ann Intern Med, 118, 495, 10.7326/0003-4819-118-7-199304010-00003 · DOI · Paper page
  110. 10.1056/NEJM199203263261301 · DOI · Paper page
  111. Slavin M, Bowden R, Osborne R, et al. Fluconazole prophylaxis in marrow transplant recipients: a randomized placebo-controlled double blind study. In: Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, Calif., October 10-14, 1992. Washington, D.C.: American Society for Microbiology, 1992:214. abstract.
  112. 10.1093/clinids/14.2.472 · DOI

Cited by

See all 596

Metadata

Authors
Wood, A. J. J., Como, J. A., & Dismukes, W. E.
Venue
New England Journal of Medicine
Published
1994-01-27
Volume
330
Issue
4
Pages
263-272
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W1967866045
Cited by
596
References
7
FWCI
45.01
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Oral Azole Drugs as Systemic Antifungal Therapy. https://app.cochat.ai/papers/10.1056/nejm199401273300407
The paper
Wood, A. J. J., Como, J. A., & Dismukes, W. E. (1994). Oral Azole Drugs as Systemic Antifungal Therapy. New England Journal of Medicine. https://doi.org/10.1056/nejm199401273300407

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.